Form 4: Unity Biotechnology Director Acquires Stock Options

Michael P. Samar, a director at Unity Biotechnology, acquired stock options for 10,000 shares on June 21, 2024.

Summary

• Michael P. Samar, a director of Unity Biotechnology, Inc. [UBX], filed a Form 4 on June 21, 2024.
• The filing reports a transaction where Mr. Samar acquired stock options for 10,000 shares of Unity Biotechnology common stock.
• The exercise price of the stock options is $1.38 per share.
• The options vest on the earlier of June 21, 2025, or the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
• Following the transaction, Mr. Samar directly owns derivative securities for 10,000 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock option grant, which is a neutral event.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as directors and officers. This allows investors to track ownership changes and potential alignment of interests between management and shareholders.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of the shareholders, as the value of the options increases if the company's stock price increases.

Key Dates